Presentation

Company Profile
Probi is a health care company active in the probiotics space, with customers both within the consumer healthcare segment and the food industry. The company was founded in 1991 and is currently one of the largest probiotic companies in the world, active in over 40 markets. Probi has its own fermentation, formulation and production capacity in GMP-certified facilities and holds around 400 patents worldwide.

Recent highlights
Q2 net sales decreased by 3%, adjusted for fx to SEK 158m (180m). The EBITDA margin was 25% (32%). The Q2 was not in line with the company´s expectations, and the Americas region explained a large part of the performance during the quarter. Net sales decreased by 5% adjusted for fx and was mainly attributable to a few larger customers that delayed orders, but also a change in customer´s product portfolios. The positive trend in the EMEA region continued, and the APAC region showed signs to be moving in the right direction. Probi sees a return to normalization on several levels. The underlying demand for its products remains strong. During and after the quarter, Probi signed new partnerships and collaborations in support for future product launches.

Outlook
The global market for probiotics is expected to continue growing in the coming years. Probi will continue to focus on sales growth, accelerating the development of new products and manufacturing excellence.